Company Filing History:
Years Active: 2014-2016
Title: **Innovative Contributions of Maria Harris: Pioneering DLL4 Binding Proteins for Cancer Treatment**
Introduction
Maria Harris is an accomplished inventor based in Shrewsbury, MA, known for her significant contributions to medical science, particularly in the field of cancer treatment. With a remarkable portfolio of seven patents, Maria has dedicated her efforts to the development of therapeutic proteins that hold the promise of combating various types of cancers through innovative mechanisms.
Latest Patents
Among her latest patented works, Maria Harris has described improved DLL4 binding proteins, which include a variety of antibodies, CDR-grafted antibodies, human antibodies, and DLL4 binding fragments. These proteins exhibit high affinity for DLL4 and possess the capability to neutralize DLL4 activity. The implications of these binding proteins are profound, as they can be utilized for treating or preventing cancers and tumors, particularly by mitigating tumor angiogenesis. Furthermore, they hold potential for addressing other angiogenesis-dependent diseases such as ocular neovascularization, as well as autoimmune disorders characterized by abnormal DLL4 expression or activity, including multiple sclerosis.
Career Highlights
Maria is currently engaged with AbbVie Inc., a leading biopharmaceutical company where her research and innovations contribute to advancements in therapeutic solutions for various diseases. Her dedication to exploring the complexities of DLL4 binding proteins stands as a testament to her commitment to enhancing cancer therapies and improving patient outcomes.
Collaborations
Throughout her career, Maria has collaborated with esteemed colleagues such as Jijie Gu and Chung-Ming Hsieh. Together, they work towards pushing the boundaries of understanding and innovating within the realm of angiogenesis and its relationship to cancer and other diseases.
Conclusion
Maria Harris is a forward-thinking inventor whose work has the potential to transform cancer treatment and improve lives. With her groundbreaking patents in DLL4 binding proteins, she exemplifies the spirit of innovation that drives research and development in the medical field. Her collaborations and achievements highlight the importance of teamwork in advancing healthcare and illustrate the impact that one dedicated inventor can have on addressing critical health challenges.